A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Clinical trial NCT05076175 · RECRUITING

Trial details

NCT number: NCT05076175
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2022-05-30
Primary completion: 2032-07-12
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.